Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs

OBJECTIVE: To examine the association between initiating first-line (1L) monotherapy with eslicarbazepine acetate (ESL) vs a generic antiseizure drug (ASD) and healthcare resource utilization (HCRU) and charges in adults with treated focal seizures (FS). METHODS: This was a retrospective analysis of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clinicoecon Outcomes Res
Main Authors: Mehta, Darshan, Davis, Matthew, Epstein, Andrew J, Wensel, Brian, Grinnell, Todd, Williams, G Rhys
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064618/
https://ncbi.nlm.nih.gov/pubmed/33907433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S303079
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki